October 2016

An update on CDK4 and CDK6 inhibitors in treatment for patients with metastatic breast cancer.

For patient autonomy and personalized cancer care, shared decision-making for AYA patients with cancer is an important strategy.

When Breast Cancer Awareness Month arrives each October, for many women there is a lot to be thankful for. Research advances have led to less aggressive treatment options and a good prognosis for women with early-stage disease, but for women with metastatic breast cancer (MBC), it is a different story.

In 2014, Novartis Oncology commissioned the Harris Poll to conduct the Make Your Dialogue Count survey to identify the emotional needs of patients newly diagnosed with metastatic breast cancer as well as during treatment change.

With the mortality rate for liver cancer rising faster than the mortality rate for any other cancer, it is important that oncology nurses are aware of risk factors, screening, and treatments so they can pass information on to their patients.

An oncology nurse's overview of inflammatory breast cancer.

Carol Bush explains a few key strategies to make LinkedIn work for your nursing career.